HMGB-1 induces cell motility and α5β1 integrin expression in human chondrosarcoma cells

Cancer Letters

Volumn 322, Issue 1, 2012, Pages 98-106

  Tang, Chih Hsin ^a,b   Keng, Yun Ting ^b   Liu, Ju Fang ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chondrosarcoma; HMGB 1; Integrin; Migration; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CELL MIGRATION; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; UPREGULATION;

BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHONDROSARCOMA; HMGB1 PROTEIN; HUMANS; INTEGRIN ALPHA5BETA1; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EUKARYOTA;

EID: 84862786797     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.014     Document Type: Article

References (46)

1. Mosevitsky M.I., Novitskaya V.A., Iogannsen M.G., Zabezhinsky M.A. Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur. J. Biochem. 1989, 185:303-310.
2. Bustin M., Lehn D.A., Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta 1990, 1049:231-243.
3. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 1999, 19:5237-5246.
4. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M., Inoue K., Yamada S., Ijiri K., Matsunaga S., Nakajima T., Komiya S., Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003, 48:971-981.
5. Pullerits R., Jonsson I.M., Verdrengh M., Bokarewa M., Andersson U., Erlandsson-Harris H., Tarkowski A. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 2003, 48:1693-1700.
6. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
7. Sunahori K., Yamamura M., Yamana J., Takasugi K., Kawashima M., Makino H. Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2006, 54:97-104.
8. Abeyama K., Eng W., Jester J.V., Vink A.A., Edelbaum D., Cockerell C.J., Bergstresser P.R., Takashima A. A role for NF-kappaB-dependent gene transactivation in sunburn. J. Clin. Invest. 2000, 105:1751-1759.
9. Okamoto H., Katagiri Y., Kiire A., Momohara S., Kamatani N. Serum amyloid A activates nuclear factor-κB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J. Rheumatol. 2008, 35:752-756.
10. Ohmori H., Luo Y., Kuniyasu H. Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer. Expert Opin. Ther. Targets 2011, 15:183-193.
11. Reismann M., Wehrmann F., Schukfeh N., Kuebler J.F., Ure B., Gluer S. Carbon dioxide, hypoxia and low pH lead to overexpression of c-myc and HMGB-1 oncogenes in neuroblastoma cells. Eur. J. Pediatr. Surg. 2009, 19:224-227.
12. Terek R.M., Schwartz G.K., Devaney K., Glantz L., Mak S., Healey J.H., Albino A.P. Chemotherapy and P-glycoprotein expression in chondrosarcoma. J. Orthop. Res. 1998, 16:585-590.
13. Yuan J., Dutton C.M., Scully S.P. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J. Orthop. Res. 2005, 23:1467-1474.
14. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
15. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer 1997, 80:1529-1537.
16. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 2000, 28:311-339.
17. Stupack D.G. The biology of integrins. Oncology (Williston Park) 2007, 21:6-12.
18. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., Muller W.J. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004, 6:159-170.
19. Heyder C., Gloria-Maercker E., Hatzmann W., Niggemann B., Zanker K.S., Dittmar T. Role of the beta1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells. Clin. Exp. Metastasis 2005, 22:99-106.
20. Seales E.C., Jurado G.A., Brunson B.A., Wakefield J.K., Frost A.R., Bellis S.L. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005, 65:4645-4652.
21. Takenaka K., Shibuya M., Takeda Y., Hibino S., Gemma A., Ono Y., Kudoh S. Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line. Int. J. Oncol. 2000, 17:1187-1194.
22. Choi J., Lee M.K., Oh K.H., Kim Y.S., Choi H.Y., Baek S.K., Jung K.Y., Woo J.S., Lee S.H., Kwon S.Y. Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line. Tumori 2011, 97:196-202.
23. Luo Y., Ohmori H., Fujii K., Moriwaka Y., Sasahira T., Kurihara M., Tatsumoto N., Sasaki T., Yamashita Y., Kuniyasu H. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer. Eur. J. Cancer 2010, 46:791-799.
24. Chen J.H., Huang S.M., Chen C.C., Tsai C.F., Yeh W.L., Chou S.J., Hsieh W.T., Lu D.Y. Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-kappaB signaling pathway in glioma cells. J. Cell. Biochem. 2011, 112:2931-2941.
25. Hsieh M.T., Hsieh C.L., Lin L.W., Wu C.R., Huang G.S. Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology. Life Sci. 2003, 73:1007-1016.
26. Wang Y.C., Lee P.J., Shih C.M., Chen H.Y., Lee C.C., Chang Y.Y., Hsu Y.T., Liang Y.J., Wang L.Y., Han W.H. Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction. Anal. Biochem. 2003, 319:206-215.
27. Huang H.C., Shi G.Y., Jiang S.J., Shi C.S., Wu C.M., Yang H.Y., Wu H.L. Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J. Biol. Chem. 2003, 278:46750-46759.
28. Tseng C.P., Huang C.L., Huang C.H., Cheng J.C., Stern A., Tseng C.H., Chiu D.T. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Lett. 2003, 541:21-27.
29. Lu D.Y., Leung Y.M., Cheung C.W., Chen Y.R., Wong K.L. Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells. Biochem. Pharmacol. 2010, 80:1201-1209.
30. Huang W.C., Chen C.C. Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol. Cell. Biol. 2005, 25:6592-6602.
31. Qin L., Chen X., Wu Y., Feng Z., He T., Wang L., Liao L., Xu J. Steroid receptor coactivator-1 upregulates integrin alpha expression to promote breast cancer cell adhesion and migration. Cancer Res. 2011, 71:1742-1751.
32. Cervella P., Silengo L., Pastore C., Altruda F. Human beta 1-integrin gene expression is regulated by two promoter regions. J. Biol. Chem. 1993, 268:5148-5155.
33. Lai T.H., Fong Y.C., Fu W.M., Yang R.S., Tang C.H. Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J. Cell. Physiol. 2009, 218:334-342.
34. Chen Y.J., Wei Y.Y., Chen H.T., Fong Y.C., Hsu C.J., Tsai C.H., Hsu H.C., Liu S.H., Tang C.H. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J. Cell. Physiol. 2009, 221:98-108.
35. Hou F.F., Jiang J.P., Guo J.Q., Wang G.B., Zhang X., Stern D.M., Schmidt A.M., Owen W.F. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J. Am. Soc. Nephrol. 2002, 13:1296-1306.
36. Bibollet-Bahena O., Almazan G. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J. Neurochem. 2009, 109:1440-1451.
37. Horowitz J.C., Lee D.Y., Waghray M., Keshamouni V.G., Thomas P.E., Zhang H., Cui Z., Thannickal V.J. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J. Biol. Chem. 2004, 279:1359-1367.
38. Huang C.Y., Fong Y.C., Lee C.Y., Chen M.Y., Tsai H.C., Hsu H.C., Tang C.H. CCL5 increases lung cancer migration via PI3K. Akt and NF-kappaB pathways. Biochemical pharmacology 2009, 77:794-803.
39. Qiao M., Sheng S., Pardee A.B. Metastasis and AKT activation. Cell Cycle 2008, 7:2991-2996.
40. Ozanne B.W., Spence H.J., McGarry L.C., Hennigan R.F. Transcription factors control invasion: AP-1 the first among equals. Oncogene 2007, 26:1-10.
41. Fong Y.C., Yang W.H., Hsu S.F., Hsu H.C., Tseng K.F., Hsu C.J., Lee C.Y., Scully S.P. 2-methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J. Orthop. Res. 2007, 25:1106-1114.
42. Hou C.H., Fong Y.C., Tang C.H. HMGB-1 induces IL-6 production in human synovial fibroblasts through c-Src, Akt and NF-kappaB pathways. J. Cell. Physiol. 2011, 226:2006-2015.
43. Franke S., Sommer M., Ruster C., Bondeva T., Marticke J., Hofmann G., Hein G., Wolf G. Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells. Arthritis Res. Ther. 2009, 11:R136.
44. Steenvoorden M.M., Toes R.E., Ronday H.K., Huizinga T.W., Degroot J. RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitro. Clin. Exp. Rheumatol. 2007, 25:740-742.
45. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 2010, 11:288-300.
46. Qureshi H.Y., Ahmad R., Sylvester J., Zafarullah M. Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cell. Signal. 2007, 19:1643-1651.